1329834-28-7

1329834-28-7 structure

Name: Ibandronic Acid-d3 sodium salt
Chemical Name: sodium,hydroxy-[1-hydroxy-3-[pentyl(trideuteriomethyl)amino]-1-phosphonopropyl]phosphinate
CAS Number: 1329834-28-7
Molecular Formula: C₉H₁₉D₃NNaO₇P₂
Molecular Weight: 344.22900
Catalog: Research Areas Cancer
Create Date: 2017-12-08 07:22:57
Modify Date: 2024-01-03 10:47:28
Ibandronic Acid-d3 sodium salt is the deuterium labeled Ibandronic acid. Ibandronic acid is a highly potent nitrogen-containing bisphosphonate used for the treatment of osteoporosis[1][2].

Name	sodium,hydroxy-[1-hydroxy-3-[pentyl(trideuteriomethyl)amino]-1-phosphonopropyl]phosphinate

Description	Ibandronic Acid-d3 sodium salt is the deuterium labeled Ibandronic acid. Ibandronic acid is a highly potent nitrogen-containing bisphosphonate used for the treatment of osteoporosis[1][2].
Related Catalog	Research Areas >> Cancer Signaling Pathways >> Others >> Others
In Vitro	Stable heavy isotopes of hydrogen, carbon, and other elements have been incorporated into drug molecules, largely as tracers for quantitation during the drug development process. Deuteration has gained attention because of its potential to affect the pharmacokinetic and metabolic profiles of drugs[1].
References	[1]. Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019;53(2):211-216. [2]. Morgan, C., S. Jeremiah, and J. Wagstaff, Metronomic administration of ibandronate and its anti-angiogenic effects in vitro. Microvasc Res, 2009. 78(3): p. 453-8. [3]. Epplen, R., et al., Differential effects of ibandronate, docetaxel and farnesol treatment alone and in combination on the growth of prostate cancer cell lines. Acta Oncol, 2011. 50(1): p. 127-33. [4]. Chesnut, I.C., et al., Effects of oral ibandronate administered daily or intermittently on fracture risk in postmenopausal osteoporosis. J Bone Miner Res, 2004. 19(8): p. 1241-9. [5]. Bauss, F., et al., Effects of treatment with ibandronate on bone mass, architecture, biomechanical properties, and bone concentration of ibandronate in ovariectomized aged rats. J Rheumatol, 2002. 29(10): p. 2200-8.

Molecular Formula	C₉H₁₉D₃NNaO₇P₂
Molecular Weight	344.22900
Exact Mass	344.09600
PSA	160.98000
LogP	0.93820

1329834-28-7	774173-70-5
1346602-32-1	138844-81-2
1329834-74-3	1130899-41-0
1215831-74-5	61199-83-5
31645-12-2	32997-86-7
1158522-08-7	940364-43-2
134104-43-1	131615-57-1
6906-52-1	930439-75-1
1018584-77-4	2171792-51-9
1375289-11-4	849349-65-1